Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa Golden

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cureus|June 12, 2023
An Interesting Case of Peripartum Cardiomyopathy With Biventricular ThrombiJoseph Abi Jaoude, Alyssa Golden-Hart, Greg Stanger, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2021
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
JAMA Network Open|July 7, 2026
Incidence of Recurrent Invasive Pneumococcal Disease in CanadaLeah J Ricketson, Altynay Shigayeva, Irina Rajakumar, et al.
American Journal of Infection Control|June 26, 2024
Group A streptococcal outbreak in a geriatric mental health unitHalima Dabaja Younis, Jennie Johnstone, Irene Armstrong, et al.
Drugs|February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial AgentGeorge G Zhanel, Doris Cheung, Heather Adam, et al.
Drugs|May 12, 2018
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 2, 2026
Invasive pneumococcal disease surveillance in Canada, 2023Alyssa Golden, Averil Griffith, Brigitte Lefebvre, et al.
Drugs|December 13, 2017
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Drugs|December 3, 2016
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial PneumoniaGeorge G Zhanel, Erika Hartel, Heather Adam, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cureus|June 12, 2023
An Interesting Case of Peripartum Cardiomyopathy With Biventricular ThrombiJoseph Abi Jaoude, Alyssa Golden-Hart, Greg Stanger, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2021
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
JAMA Network Open|July 7, 2026
Incidence of Recurrent Invasive Pneumococcal Disease in CanadaLeah J Ricketson, Altynay Shigayeva, Irina Rajakumar, et al.
American Journal of Infection Control|June 26, 2024
Group A streptococcal outbreak in a geriatric mental health unitHalima Dabaja Younis, Jennie Johnstone, Irene Armstrong, et al.
Drugs|February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial AgentGeorge G Zhanel, Doris Cheung, Heather Adam, et al.
Drugs|May 12, 2018
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 2, 2026
Invasive pneumococcal disease surveillance in Canada, 2023Alyssa Golden, Averil Griffith, Brigitte Lefebvre, et al.
Drugs|December 13, 2017
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Drugs|December 3, 2016
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial PneumoniaGeorge G Zhanel, Erika Hartel, Heather Adam, et al.
Pageof 2